HK1048821B - 噻吩a2a受體激動劑 - Google Patents

噻吩a2a受體激動劑

Info

Publication number
HK1048821B
HK1048821B HK03101016.5A HK03101016A HK1048821B HK 1048821 B HK1048821 B HK 1048821B HK 03101016 A HK03101016 A HK 03101016A HK 1048821 B HK1048821 B HK 1048821B
Authority
HK
Hong Kong
Prior art keywords
thiophene
receptor agonists
disclosed
purposes
alkylthienyl
Prior art date
Application number
HK03101016.5A
Other languages
English (en)
Other versions
HK1048821A1 (en
Inventor
杰夫‧A‧扎布洛茨基
埃費提‧O‧埃爾策英
文卡塔‧P‧帕列
Original Assignee
Cv治療公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv治療公司 filed Critical Cv治療公司
Publication of HK1048821A1 publication Critical patent/HK1048821A1/xx
Publication of HK1048821B publication Critical patent/HK1048821B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03101016.5A 1999-06-22 2003-02-12 噻吩a2a受體激動劑 HK1048821B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22
PCT/US2000/016856 WO2000078776A2 (en) 1999-06-22 2000-06-20 Thiophene a2a receptor agonists

Publications (2)

Publication Number Publication Date
HK1048821A1 HK1048821A1 (en) 2003-04-17
HK1048821B true HK1048821B (zh) 2005-02-25

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101016.5A HK1048821B (zh) 1999-06-22 2003-02-12 噻吩a2a受體激動劑

Country Status (19)

Country Link
US (1) US6440948B1 (zh)
EP (1) EP1194441B1 (zh)
JP (1) JP2003502434A (zh)
KR (1) KR100463694B1 (zh)
CN (1) CN1166677C (zh)
AT (1) ATE252595T1 (zh)
AU (1) AU768530B2 (zh)
BR (1) BR0011853A (zh)
CA (1) CA2373410C (zh)
DE (1) DE60006116T2 (zh)
ES (1) ES2206259T3 (zh)
HK (1) HK1048821B (zh)
IL (2) IL147194A0 (zh)
MX (1) MXPA01013323A (zh)
NO (1) NO20016242L (zh)
NZ (1) NZ516336A (zh)
TR (1) TR200200617T2 (zh)
WO (1) WO2000078776A2 (zh)
ZA (1) ZA200200299B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023457A1 (en) * 1998-10-16 2000-04-27 Pfizer Limited Adenine derivatives
CN1279984C (zh) 2002-02-15 2006-10-18 Cv医药有限公司 用于医用装置的聚合物涂层
TWI346109B (en) 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
PT1758596E (pt) * 2004-05-26 2010-06-23 Inotek Pharmaceuticals Corp Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização
AU2005286946B2 (en) * 2004-09-20 2012-03-15 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
BRPI0619261A2 (pt) * 2005-11-30 2011-09-27 Inotek Pharmaceuticals Corp derivados de purina e métodos de uso desses
ES2613698T3 (es) 2010-01-11 2017-05-25 Inotek Pharmaceuticals Corporation Combinación, kit y método de reducción de la presión intraocular
US8476247B2 (en) 2010-03-26 2013-07-02 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans
LT2807178T (lt) 2012-01-26 2017-08-25 Inotek Pharmaceuticals Corporation (2r,3s,4r,5r)-5-(6-(ciklopentilamino)-9h-purin-9-il)-3,4-dihidroksitetrahidrofuran-2-il) } metilnitrato bevandeniai polimorfai ir jų gavimo būdai
CA2903114A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations
US20210128699A1 (en) 2017-01-13 2021-05-06 Tobishi Pharmaceutical Co., Ltd. Neutrophil activation regulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (zh) * 1972-05-15 1974-02-01
JPS5518625B2 (zh) * 1973-07-26 1980-05-20
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
PL297372A1 (en) * 1991-04-06 1993-09-06 Fisons Plc Atp analogs

Also Published As

Publication number Publication date
AU5625100A (en) 2001-01-09
NO20016242D0 (no) 2001-12-19
US6440948B1 (en) 2002-08-27
MXPA01013323A (es) 2003-10-15
CN1364170A (zh) 2002-08-14
EP1194441A2 (en) 2002-04-10
DE60006116D1 (de) 2003-11-27
JP2003502434A (ja) 2003-01-21
HK1048821A1 (en) 2003-04-17
TR200200617T2 (tr) 2002-06-21
WO2000078776A2 (en) 2000-12-28
IL147194A0 (en) 2002-08-14
CA2373410A1 (en) 2000-12-28
WO2000078776A3 (en) 2001-06-28
ES2206259T3 (es) 2004-05-16
KR100463694B1 (ko) 2004-12-29
ZA200200299B (en) 2003-08-27
IL147194A (en) 2007-08-19
NZ516336A (en) 2004-01-30
EP1194441B1 (en) 2003-10-22
KR20020028912A (ko) 2002-04-17
CN1166677C (zh) 2004-09-15
CA2373410C (en) 2006-08-29
ATE252595T1 (de) 2003-11-15
AU768530B2 (en) 2003-12-18
NO20016242L (no) 2002-02-21
DE60006116T2 (de) 2004-07-08
BR0011853A (pt) 2002-04-30

Similar Documents

Publication Publication Date Title
CA2377746A1 (en) N-pyrazole a2a receptor agonists
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
ZA200200299B (en) Thiophene A2A receptor agonists.
MA26699A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2375385A1 (en) Propargyl phenyl ether a2a receptor agonists
MY148937A (en) Medicaments with hm74a receptor activity
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
LU91599I2 (fr) Lasofoxifene, optionnellement sous forme d'un sel d'addition acide, d'un N-oxyde, d'unester ou d'un sel d'ammonium quaternaire, non toxiques et pharmacologiquement acceptables, y compris le sel tartrate (FABLYN - lasofoxifene)
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
EP1797878A3 (en) Benzothiazole derivatives
ATE433959T1 (de) Analoge von kokain
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
DE50211929D1 (en) Pyrimidinderivate
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
PL335016A1 (en) Novel polymorph of 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl]-1-phtalazine acetic acid monohydrate, method of obtaining same, method of obtaining anhydrous 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl-1-phtalazine acetic acid, therapeutic methods, pharmaceutic agent, application of said polymorph in production of such pharmaceutic agent and method of obtaining the last mentioned one
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
UA74421C2 (uk) Похідні індолону, які є антагоністами gal3 рецептора для лікування депресії і/або тривоги та композиції, придатні для такого лікування
CA2304821A1 (en) Osteoblast-specific mitogens and drugs containing such compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120620